Dr Phillip (Pip) LR Nicolson MA MB BChir (Cantab) PhD FRCP FRCPath

Dr Pip Nicolson

Department of Cardiovascular Sciences
Associate Clinical Professor in Cardiovascular Medicine (Haematology)

Contact details

Address
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Pip is clinical academic with a clinical interest in haemostasis, thrombosis and immunohaematology. He has a laboratory research interest in the role of platelets in venous thrombosis and thromboinflammation. He is passionate about efficient clinical research in these areas.

Qualifications

  • Fellowship of the Royal College of Physicians (UK) 2025
  • Fellowship of the Royal College of Pathologists, 2020
  • PhD, University of Birmingham, 2019
  • Membership of the Royal College of Physicians (UK) 2011
  • MA (Natural Sciences), University of Cambridge, 2009
  • MB BChir, University of Cambridge, 2008
  • BA (Natural Sciences), University of Cambridge, 2005

Biography

He works in the Birmingham Platelet Group and in the department of Haematology at the Queen Elizabeth Hospital, Birmingham. He is president of the UK-wide, registrar-led research network HaemSTAR and was awarded the BSH-NIHR Researcher of the year award in 2019 and the Royal College of Pathologists Furness Prize for science communication for his work with this group. He is a drummer and keen cyclist, regularly participating in domestic and international sportives and century rides.

Teaching

  • Dental Sciences (Non-malignant haematology)
  • Medical Sciences (Cardiovascular Physiology)

Postgraduate supervision

  • Supervisor to PhD students
  • Supervisor to MRes students
  • Supervisor to Intercalating medical students
  • Personal Academic Tutor to Medical Students

Research

  • Investigating the role of platelet ITAM receptors in human venous thrombosis and thromboinflammation.
  • Changing the non-malignant haematology research landscape using mass participation clinical studies mediated via HaemSTAR & HaemTRIAL

Fellowship and Grant Awards 

  • 2023 BHF Project Grant (Co-I)
  • 2023 Acticor Biotech Research Grant (Co-I)
  • 2022 Wellcome Trust Translational Discovery Fund Award (Co-I)
  • 2021 NIHR Project Grant (Co-I)
  • 2021 Sanofi Research Grant (PI)
  • 2021 BHF Accelerator Award (PI)
  • 2020 Dynamic Investment Fund Award (PI)
  • 2020 BHF Accelerator Award (PI)
  • 2019 Principia Biopharma Research Grant (PI)
  • 2019 MRC Proximity to Discovery Grant (PI)
  • 2019 BSHT Summer Studentship
  • 2018 - Novartis Pharmaceuticals Research Grant (PI)
  • 2018 - Rigel Pharmaceuticals Research grant (Sub I)
  • 2018 - SACC Katie Bolam Research Award (PI)
  • 2017 - BHF Clinical Research Training Fellowship
  • 2015 - ITM Starter Fellowship

Grant Awards (HaemSTAR)

  • 2022 AstraZeneca Research Grant
  • 2022 Dudley Leukaemia Unit Appeal Fund Grant
  • 2019 Sanofi Unrestricted Grant
  • 2019 Octapharma Unrestricted Grant

Research Groups 

Other activities

  • Founder of HaemTRIAL: Haematology Trials, Research, Innovation & Learning.
  • Founder and President of HaemSTAR: Haematology Specialist Training, Audit & Research.
  • Member of the British Society of Haematology Research & Grants Committee.

Publications

Recent publications

Article

HaemSTAR Collaborators, Nicolson, P & Pettitt, M 2025, 'A UK-wide analysis of 2265 patients receiving a reversal agent for direct oral anticoagulant-associated bleeding', Journal of Thrombosis and Haemostasis.

Hassan, E, Sutton, D, Buka, R, Lowe, G, Nandra, T, Jacob, N, Rose, L, Alhamdi, Y, HaemSTAR Collaborators & Nicolson, P 2025, 'Disparities in menstrual bleeding management during acute venous thromboembolism treatment: A review of UK practice and a call for clinical studies', Thrombosis Research, vol. 247, 109258. https://doi.org/10.1016/j.thromres.2025.109258.

HaemSTAR Collaborators 2025, 'Physician Survey on the Management of Pulmonary Embolism in Pregnancy: Need for Guidance and Training', EJHaem, vol. 6, no. 4, e70113. https://doi.org/10.1002/jha2.70113

El-awaisi, J, Perrella, G, Mayer, N, Tinkova, V, Simon, CJ, Grygielska, B, Watson, SP, Dimitrov, JD, Brill, A, Hassan, E, Nicolson, PLR, Kavanagh, D, Kalia, N & Rayes, J 2025, 'Spleen tyrosine kinase inhibition mitigates hemin-induced thromboinflammation in an organ-specific manner in sickle cell mice', Arteriosclerosis Thrombosis and Vascular Biology. https://doi.org/10.1161/ATVBAHA.124.32207

Nicolson, PLR, Abrams, ST, Amirthalingam, G, Brown, K, Buka, RJ, Caulfield, MJ, Gardner, J, Goldblatt, D, Lovatt, C, Montague, SJ, Naisbitt, D, Parker, AL, Pavord, S, Ramsay, ME, Sterne, JAC, Sudlow, CLM, Toh, C-H, Watson, SP, Wang, G, Wood, AM, Whiteley, W & Pirmohamed, M 2025, 'Understanding Mechanisms of Thrombosis and Thrombocytopenia with Adenoviral SARS-CoV-2 Vaccines: A Comprehensive Synopsis', Efficacy and Mechanism Evaluation, vol. 12, no. 7, pp. 1-36. https://doi.org/10.3310/FFSS9010

Nicolson, PLR, Belete, M, Hawes, R, Fowler, N & Toh, C-H 2024, 'Alternative routes into clinical research: a guide for early career doctors', BMJ, vol. 385, e076414. https://doi.org/10.1136/bmj-2023-076414

Gardner, J, Abrams, ST, Toh, C-H, Parker, AL, Lovatt, C, Nicolson, PLR, Watson, SP, Grice, S, Hering, L, Pirmohamed, M & Naisbitt, DJ 2024, 'Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines', NPJ vaccines, vol. 9, no. 1, 99. https://doi.org/10.1038/s41541-024-00895-z

Cooper, N, Scully, M, Percy, C, Nicolson, P, Lowe, G, Bagot, C, Thachil, J, Grech, H, Noakes, T, Hill, Q, Bradbury, C, Talks, K, Dutt, T, Evans, G, Pavord, S, Wexler, SK, Charania, A, Collington, SJ, Ervin, A, Ramscar, N & Provan, D 2024, 'Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study', British Journal of Haematology. https://doi.org/10.1111/bjh.19345

Smith, C, Campos, J, Brown, H, Ivanova, V-S, Harbi, M, Garcia Quintanilla, L, Jossi, S, Perez-Toledo, M, Rookes, K, Brill, A, Theodore, L, Owens, T, LaStant, J, Foulke, MC, Mukai, S, Francesco, M, Storek, M, Hicks, A, Langrish, C, Nunn, PA, Cunningham, A, Chauhan, A, Thomas, MR, Watson, S & Nicolson, P 2024, 'Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2 & PRN473 reduces venous thrombosis formation in mice', Blood Advances. https://doi.org/10.1182/bloodadvances.2024012713

Sherratt-Mayhew, S & Nicolson, P 2024, 'Use of IV Immunoglobulin to Treat Steroid Resistant, Immune Checkpoint Inhibitor induced Pure Red Cell Aplasia: A Case Report', EJHaem. https://doi.org/10.1002/jha2.937

Comment/debate

Buka, R, Nicolson, P & Sutton, D 2024, 'Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate', Journal of Thrombosis and Thrombolysis, vol. 57, pp. 739-741. https://doi.org/10.1007/s11239-024-02948-5

Letter

Nicolson, P, Montague, S, Buka, R, Calvert, A, Sheppard, J-A, Zhang, Y, Wang, JJ, Sharman, J, Hassan, E, Harrison, J, Lawrence, E, El-Dalil, P, Parekh, D, Osman, H, Gordon, T, Nazy, I, Warkentin, T & Lester, W 2025, 'Anti-PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT-like and VITT-like characteristics', British Journal of Haematology. https://doi.org/10.1111/bjh.20092

Nicolson, PLR, Asif, M, Buka, RJ, Dyer, P, Hassan, E, Harrison, CN, Maybury, BD & Doyle, AJ 2025, 'Common themes and uncertainties in management of secondary polycythaemia: an international clinician survey of practice', EJHaem, vol. 6, no. 6, e70171. https://doi.org/10.1002/jha2.70171

Hassan, E, Fratter, C, Lester, W, Percy, C, Saad, W, Alkhedir, A, Motwani, J, Bagnell, P, Nicolson, PLR, Morgan, NV, Potluri, S & Lowe, G 2025, 'The diagnostic utility of genetic testing in inherited thrombocytopenia: regional multicenter tertiary experience', Research and Practice in Thrombosis and Haemostasis, vol. 9, no. 3, 102869. https://doi.org/10.1016/j.rpth.2025.102869

HaemSTAR Collaborators 2025, 'Venesection and resolution of erythrocytosis are not associated with reduced thrombotic risk in secondary and idiopathic polycythaemia: Results from a dual centre, 5‐year retrospective study', British Journal of Haematology. https://doi.org/10.1111/bjh.20235

View all publications in research portal